Srivastava Shanti Swaroop, Darling Joseph E, Suryadi Jimmy, Morris James C, Drew Mark E, Subramaniam Sriram
University of British Columbia, Vancouver, British Columbia, Canada.
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
IUCrJ. 2020 Mar 26;7(Pt 3):453-461. doi: 10.1107/S2052252520002456. eCollection 2020 May 1.
Malaria is a devastating disease caused by a protozoan parasite. It affects over 300 million individuals and results in over 400 000 deaths annually, most of whom are young children under the age of five. Hexokinase, the first enzyme in glucose metabolism, plays an important role in the infection process and represents a promising target for therapeutic intervention. Here, cryo-EM structures of two conformational states of hexokinase (PvHK) are reported at resolutions of ∼3 Å. It is shown that unlike other known hexokinase structures, PvHK displays a unique tetrameric organization (∼220 kDa) that can exist in either open or closed quaternary conformational states. Despite the resemblance of the active site of PvHK to its mammalian counterparts, this tetrameric organization is distinct from that of human hexokinases, providing a foundation for the structure-guided design of parasite-selective antimalarial drugs.
疟疾是一种由原生动物寄生虫引起的毁灭性疾病。它每年影响超过3亿人,并导致超过40万人死亡,其中大多数是5岁以下的幼儿。己糖激酶是葡萄糖代谢中的第一种酶,在感染过程中起重要作用,是治疗干预的一个有前景的靶点。在此,报道了己糖激酶(PvHK)两种构象状态的冷冻电镜结构,分辨率约为3埃。结果表明,与其他已知的己糖激酶结构不同,PvHK呈现独特的四聚体结构(约220 kDa),可以以开放或封闭的四级构象状态存在。尽管PvHK的活性位点与其哺乳动物对应物相似,但这种四聚体结构与人类己糖激酶不同,为基于结构的寄生虫选择性抗疟药物设计提供了基础。